Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DC72LG
|
|||
| Drug Name |
RMJH-111b
|
|||
| Synonyms |
Trimagnesium dicitrate; MAGNESIUM CITRATE; 3344-18-1; Trimagnesium citrate; UNII-RHO26O1T9V; magnesium dicitrate; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, magnesium salt (2:3); 7779-25-1; RHO26O1T9V; Magnesium citrate, Mg3(C6H5O7)2; trimagnesium;2-hydroxypropane-1,2,3-tricarboxylate; Trimagnesiumdicitrat; MAGNESIUMCITRATE; NSC-83517; Magnesium citrate (VAN); Magnesium citrate [USP]; Magnesium citrate (3:2); Trimagnesiumdicitrate; EINECS 222-093-9; Tectlol (TN); NSC 83517; Tri Magnesium Citrate; EC 222-093-9; Magnesium citrate (JAN/USP); C12H10Mg3O14; CHEMBL3989480; CHEBI:131391; DTXSID601015151; AKOS028109620; DB11110; H259; DB-048405; Citric acid, magnesium salt (2:3) (8CI); FT-0628080; FT-0628081; D03265; Q4177438; magnesium 2-hydroxypropane-1,2,3-tricarboxylate (3/2); 1,2,3-Propanetricarboxylic acid, hydroxy-, magnesium salt (2:3); 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, magnesium salt (2:3) (9CI); Citric acid, magnesium salt (2:3), Citric acid, magnesium salt (2:3) (8CI), EINECS 222-093-9, LS-121081, MAGNESIUM CITRATE, Magnesium citrate (3:2), Magnesium citrate, Mg3(C6H5O7)2, Magnesium; MAGNESIUM CITRATE, Magnesium citrate (3:2), Magnesium citrate, Mg3(C6H5O7)2, Magnesium citrate [USAN], Magnesium citrate (VAN), NSC 83517, Trimagnesiumdicitrat, Trimagnesium dicitrate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Essential hypertension [ICD-11: BA00; ICD-10: I10; ICD-9: 401] | Phase 1/2 | [1] | |
| Company |
RMJ Holdings
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C12H10Mg3O14
|
|||
| Canonical SMILES |
C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Mg+2].[Mg+2].[Mg+2]
|
|||
| InChI |
1S/2C6H8O7.3Mg/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;;3*+2/p-6
|
|||
| InChIKey |
PLSARIKBYIPYPF-UHFFFAOYSA-H
|
|||
| CAS Number |
CAS 3344-18-1
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:131391
|
|||
| ADReCS Drug ID | BADD_D01341 | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02822222) Safety Study of RMJH-111b to Treat Essential Hypertension. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.